We report on a preterm neonate of 30 weeks gestational age who presented with marked muscular hypotonia and severe respiratory failure at birth and was diagnosed with congenital myotonic dystrophy.
Eligible participants included individuals aged 12 years or older with a diagnosis of myotonic dystrophy type 1, excluding those with congenital myotonic dystrophy. Participants were required to ...
In recent years, a growing understanding of myotonic dystrophy type 1 (DM1)—an often fatal, devastating, rare neuromuscular disorder that causes muscle weakness and other life-limiting ...
4d
News Medical on MSNRestoring heart function in Myotonic Dystrophy Type 1Researchers at Baylor College of Medicine and their collaborators focused on Myotonic Dystrophy 1 heart problems testing a novel approach to restore normal function.
Hosted on MSN9mon
New cellular models of myotonic dystrophy type 1 reflect the clinical diversity of the diseaseMyotonic dystrophy type 1 (DM1 ... Patients with an earlier onset age - juvenile, infantile, or even congenital - tend to be more severely affected. Beyond classical cellular models Researchers ...
Myotonic dystrophy type 1 (DM1), a genetic disorder, shares overlapping features with chronic kidney disease, including ...
Patients with myotonic dystrophy have smaller hearts, and lower systolic and diastolic blood pressures and pulse rates. They have impaired autonomic reflexes, measured by orthostatic, Valsalva ...
14d
News-Medical.Net on MSNResearch links kidney dysfunction to muscle weakness in myotonic dystrophy type 1Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, "Analysis of human urinary extracellular ...
About the rSM Program to Treat Myotonic Dystrophy Type 1 (DM1) Myotonic dystrophy type 1 (DM1) is a form of muscular dystrophy and a genetic neuromuscular disease affecting at least 1 in 8,000 ...
Learning from examples like congenital heart disease and cystic fibrosis can help health systems and clinicians prepare to care for an influx of patients with neuromuscular diseases as they reach ...
They are actively studying the use of implantable cardioverter defibrillators (ICDs) in children with congenital heart disease ... of new arrhythmia pathways associated with myotonic dystrophy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results